CNN

Newly approved antibody could offer another option for protecting infants from RSV, a common infection that can be deadly

The United States could soon have another tool in the fight against respiratory syncytial virus, an illness that’s the No. 1 cause of hospitalization in infants. The US Food and Drug Administration ...
Scientific American

A Tragic Vaccine Failure Led to a Breakthrough: How Scientists Finally Tamed RSV

Tragic RSV vaccine trials in the 1960s set the field back for decades. Here’s how scientists finally made breakthroughs in RSV immunization ...
Medscape

Chronic Medical Conditions Raise Risk for Respiratory Syncytial Virus Hospitalizations in Children

Children with chronic medical conditions (CMCs) had higher rates of respiratory syncytial virus (RSV)-related hospitalization than healthy children during their first two RSV seasons, with a sustained ...
Medscape

Don’t Wait: New Data Back RSV Vaccines Ahead of Fall Surge

If your patient is pregnant or older than 60 years and due for a respiratory syncytial virus (RSV) shot, now’s the time to act. A major new review highlighted the vaccine’s impact and safety, ...

GSK to launch late-stage testing of syncytial virus vaccine

GlaxoSmithKline said it would move its experimental vaccine against the respiratory syncytial virus (RSV), a cause of pneumonia in toddlers and the elderly, into the final stage of testing, encouraged ...